Navigation Links
Isolagen, Inc. Reports Positive Top-line Results from Phase II/III Study of Isolagen Therapy(TM) to Treat Moderate to Severe Acne Scars: Study Meets All Primary Efficacy Endpoints and is Statistically Significant
Date:3/5/2009

tic applications including wrinkles, acne scars, burns and periodontal disease. Isolagen also commercializes a scientifically-advanced line of skincare systems through its majority-owned subsidiary, Agera(R) Laboratories, Inc. For additional information, please visit www.isolagen.com.

Isolagen Forward Looking Statements

All statements in this news release that are not based on historical fact are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and the provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include, without limitation, FDA concurrence with the use of the Company's Evaluator Live Acne Scar Assessment scale, the Company's ability to complete, at a minimum, an additional Phase III study to complement study IT-A-008 in order to pursue FDA approval and licensure, the Company's ability to complete any financings or enter into any strategic partnerships, and the timely filing of the Biologics Licensing Application (BLA) with the FDA,. While management has based any forward-looking statements contained herein on its current expectations, the information on which such expectations were based may change. These forward-looking statements rely on a number of assumptions concerning future events and are subject to a number of risks, uncertainties, and other factors, many of which are outside of our control, that could cause actual results to materially differ from such statements. Such risks, uncertainties, and other factors include, but are not necessarily limited to, those set forth under Item 1A "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2007, as updated in "Item 1A. Risk Factors" in the Company's Quarterly Reports on Form 10-Q. We operate in a highly competitive and
'/>"/>

SOURCE Isolagen, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Isolagen, Inc. Completes Enrollment in Isolagen Therapy(TM) Phase II/III Acne Scar Study
2. Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Spherix Reports Second Quarter Earnings
5. Tapestry Reports Second Quarter 2007 Results
6. Callisto Reports on Second-Quarter 2007 Milestones
7. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
8. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
9. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
10. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
11. Biopure Reports on Meeting with the FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... 28, 2015  Perrigo Company plc ("Perrigo") (NYSE: ... the acquisition of leading OTC brands from GSK in ... transaction is a clear demonstration of Perrigo,s unique ability ... distribution network spanning 36 countries.  Perrigo ... commented, "We are excited to complete this transaction, which ...
(Date:8/28/2015)... Massachusetts y LONDRES, 28 de agosto ... AEX: PHIA) anunció hoy su participación en el  ... exhibirá sus soluciones cardiológicas más recientes y novedosas, ... Cardiovascular, que conectan a las personas y la ... de ayudar a diagnosticar, guiar los tratamientos y ...
(Date:8/27/2015)... DURECT Corporation (Nasdaq: DRRX ) announced ... upcoming healthcare conferences.  , James ... the Rodman & Renshaw Investment Conference on Thursday, September ... being held at the St. Regis Hotel in ... webcast of the presentation will be available by accessing ...
Breaking Medicine Technology:Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 2Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 3Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 4Philips presenta nuevas soluciones cardiológicas integradas para desarrollar procedimientos menos invasivos 5DURECT to Participate in Upcoming Healthcare Conferences 2
... , ALLEGAN, Mich., Nov. 19 Perrigo Company ... and CEO Joseph C. Papa will present at the Sidoti ... (EST) at the Grand Hyatt Hotel in New York City. ... supplier that develops, manufactures and distributes OTC and prescription pharmaceuticals, ...
... Nov. 19 Delcath Systems, Inc. (Nasdaq: DCTH ), ... (PHP(TM)) System, a minimally invasive drug delivery platform for the ... on the Company,s recent progress. , "Since we last communicated ... many significant milestones as we move into the first regulatory ...
Cached Medicine Technology:Delcath Systems Reports Substantial Progress 2Delcath Systems Reports Substantial Progress 3Delcath Systems Reports Substantial Progress 4
(Date:8/29/2015)... ... August 29, 2015 , ... ... extend and improve the lives of patients, according to a newly published report. ... to read the full article. , The authors of the new paper ...
(Date:8/29/2015)... Viejo, CA (PRWEB) , ... August 29, 2015 , ... ... Pro X . Each preset contains 15 seconds of unique footage that users can ... that rise, fall, zoom, attract and more. Users can customize color, brightness, scale, speed, ...
(Date:8/29/2015)... TX (PRWEB) , ... August 29, 2015 , ... ... allows the company to freely market and sell Arterosil and Arterosil HP, and ... Health Sciences, LLC (DHS) sued Vascular Health Sciences, LLC (VHS) in the United ...
(Date:8/28/2015)... ... August 28, 2015 , ... Approximately 2,000 United Methodists ... celebrate children helping children, a thank you to the many creative and generous ... to the United Methodist initiative to end malaria deaths. , The Columbus Zoo ...
(Date:8/28/2015)... ... August 28, 2015 , ... For Dallas, the time ... part with their subsidiary USPI Tenet Health. , The American Heart Association hosts their ... and stroke. They believe that together, a difference can be made. Walkers can participate ...
Breaking Medicine News(10 mins):Health News:Top Mesothelioma Researchers Highlight Targeted Therapies in New Report, According to Surviving Mesothelioma 2Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 2Health News:Saturday’s United Methodist Event at Columbus Zoo Celebrates Imagine No Malaria 3Health News:North Central Surgical Center’s Subsidiary Participates in Walk 2
... &,Johnson will participate in the 28th Annual Cowen ... at the Boston Marriott Copley Place,Hotel in Boston, ... the Company in a session scheduled at 11:00,a.m. ... to investors and other interested parties,by accessing the ...
... of evidence suggests the medications speed tumor growth, shorten ... a U.S. Food and Drug Administration advisory panel meets ... use in cancer patients suffering from anemia, the question ... , According to FDA briefing documents filed this week, ...
... 800% heading into spring, PORT WASHINGTON, N.Y., March ... falling apart. Due to unemployment, foreclosures and gas at,an ... their wallets.,People are becoming more and more apprehensive about ... programs. Consumers are,having a tough time trying to justify ...
... Big at Arnold Classic; Says ... -, PHOENIX, March 13 NutraCea (OTC Bulletin,Board: ... nutrient,research and technology announced today that champion powerlifter Mike,Bridges, ... with a squat lift of 716 pounds in the ...
... for ... remote workforce, ... health insurance organization, sought a trusted,method to enable secure enterprise ... Universa selected Entrust,Inc. (Nasdaq: ENTU ) and the Entrust ...
... eScriptMessenger Eases Compliance with Upcoming Federal Mandates, ... the leading provider,of next generation healthcare connectivity ... has selected Kryptiq,s eScriptMessenger(TM),(eSM) as its enterprise ... to date, will enable BMC prescribers to ...
Cached Medicine News:Health News:FDA Panel Weighs Safety of Anemia Drugs for Cancer Patients 2Health News:FDA Panel Weighs Safety of Anemia Drugs for Cancer Patients 3Health News:Lose Weight This Spring With Portion Control Diet Tool 2Health News:New World Record Holder in Powerlifting Credits NutraCea's Unique Rice-Bran-derived Product as his 'Secret Weapon' 2Health News:New World Record Holder in Powerlifting Credits NutraCea's Unique Rice-Bran-derived Product as his 'Secret Weapon' 3Health News:New World Record Holder in Powerlifting Credits NutraCea's Unique Rice-Bran-derived Product as his 'Secret Weapon' 4Health News:Enabling the Mobile Workforce ... Entrust Deploys Strong Authentication for German Health Insurance Expert 2Health News:Enabling the Mobile Workforce ... Entrust Deploys Strong Authentication for German Health Insurance Expert 3Health News:Boston Medical Center Meets Prescription Challenges With Kryptiq ePrescribing Solution 2Health News:Boston Medical Center Meets Prescription Challenges With Kryptiq ePrescribing Solution 3
9 mm diameter pigtail curved blunt probes. Stainless steel. Round knurled handle with polished finish. Includes pre-cut polyethylene tubes. Overall length: 5.9 inches....
The Novus 2000 argon laser combines power, size, and versatility. Ideal for the office, clinic and operating room environments, Novus 2000 is the world's most widely accepted ophthalmic laser....
Practice-oriented ophthalmic laser systems for photodisruption....
... determining color vision abnormalities and testing color ... applied to many psychological and industrial color ... trays containing a total of 85 removable ... variation on one side and are numbered ...
Medicine Products: